Role of apelin in physiology and diseases of cardiovascular system;Rola apeliny w fizjologii i chorobach układu sercowo-naczyniowego

Polski Przeglad Kardiologiczny

Volumn 10, Issue 1, 2008, Pages 55-58

  Kotwica, Tomasz ^a   Kosmala, Wojciech ^a  

^a Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

Author keywords

Apelin; APJ receptor; Cardiovascular diseases

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; APELIN; APELIN RECEPTOR; NITRIC OXIDE; VASOPRESSIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; HEART FAILURE; HEART PROTECTION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VASODILATATION; VASOPRESSIN RELEASE;

EID: 42949131184     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. O'Dowd BF, Heiber M, Chan A, i wsp. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene. 1993;136:355-360.
2. Tatemoto K, Hosoya M, Habata Y, i wsp. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251:471-476.
3. Kawamata Y, Habata Y, Fukusumi S, i wsp. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta. 2001;1538:162-171.
4. Habata Y, Fujii R, Hosoya M, i wsp. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrums. Biochim Biophys Acta. 1999;1452:25-35.
5. Lee DK, Cheng R, Nguyen T, i wsp. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74:34-41.
6. 1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol. 2001; 132:1255-1260.
7. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005;107:198-211.
8. Kagiyama S, Fukuhara M, Matsumura K, i wsp. Central and peripheral cardiovascular actions of apelin in conscious rats. Regul Pept. 2005;125:55-59.
9. Charles CJ. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem. 2007;5:1-10.
10. De Mota N, Goazigo ARL, El Messari S, i wsp. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neurons activity and vasopressin relese. Proc Natl Acad Sci USA. 2004;101: 10464-10469.
11. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept. 2004;118:119-125.
12. Tatemoto K, Takayamab K, Zoua MX, i wsp. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept. 2001; 99:87-92.
13. El Messari S, Iturrioz X, Fassot C, i wsp. Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem. 2004;90:1290-1301.
14. Cheng X, Cheng XS, Pang CCY. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol. 2003;470:171-175.
15. Charles CJ, Rademaker MT, Richards AM. Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep. J Endocrinol. 2006;189:701-710.
16. Ishida J, Hashimoto T, Hashimoto Y, i wsp. Regulatoty roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem. 2004;279:26274-26279.
17. Szokodi I, Tavi P, Folder G, i wsp. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res. 2002;91:434-440.
18. Berry MF, Pirolli TJ, Jayasankar V, i wsp. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation. 2004;110:187-193.
19. Ashley EA, Powers J, Chen M, i wsp. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res. 2005;65:73-82.
20. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol. 2006;553:222-228.
21. Farkasfalvi K, Stagg MA, Coppen SR, i wsp. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun. 2007;357:889-895.
22. Jia YX, Pan CS, Zhang J, i wsp. Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept. 2006;133:147-154.
23. Zhang J, Ren CX, Qi YF, i wsp. Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. Life Sci. 2006;79:1153-1159.
24. Zhong JC, Huang DY, Liu GF, i wsp. Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res. 2005;65:743-750.
25. Ronkainen VP, Ronkainen JJ, Hanninen SL, i wsp. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J. 2007;21: 1821-1830.
26. Foldes G, Horkay F, Szokodi I, i wsp. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun. 2003;308:480-485.
27. Chong KS, Gardner RS, Morton JJ, i wsp. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail. 2006;8:355-360.
28. Chen MM, Ashley EA, Deng DXFN, i wsp. Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction. Circulation. 2003;108: 1432-1439.
29. Ellinor PT, Low AF, Macrae CA. Reduced apelin levels in lone atrial fibrillation. Eur Heart J. 2006;27:222-226.
30. Goetze JP, Rehfeld JF, Carlsen J, i wsp. Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept. 2006;133:134-138.